GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (FRA:BHM) » Definitions » Investments And Advances

Bachem Holding AG (FRA:BHM) Investments And Advances : €0.0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bachem Holding AG Investments And Advances?

Bachem Holding AG's Investments And Advances for the quarter that ended in Dec. 2024 was €0.0 Mil.


Bachem Holding AG Investments And Advances Historical Data

The historical data trend for Bachem Holding AG's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG Investments And Advances Chart

Bachem Holding AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bachem Holding AG Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bachem Holding AG Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Bachem Holding AG Business Description

Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and USA. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.